DSD-T270

5-alpha reductase deficiency · 46,XY · DSD-T270

DSD-T270 · 5α-reductase deficiency · 2022 · Automated translation

Genes NR5A1 · Karyotype 46,XY · Phenotypes HPO:0000028, Cryptorchidism (HP:0000028)

11β-羟化酶缺陷症(CYP11B1 p.Arg448His纯合)致先天性肾上腺增生症、抵抗性高血压及双侧睾丸肾上腺残余瘤。

Case fields and evidence

Category

5-alpha reductase deficiency

Age

中年男性(原文未报告具体年龄)

Karyotype

46,XY

Genetics

NR5A1

Phenotypes

Cryptorchidism (HP:0000028)

Diagnosis

11β-羟化酶缺陷症(CYP11B1 p.Arg448His纯合)致先天性肾上腺增生症、抵抗性高血压及双侧睾丸肾上腺残余瘤。

Follow-up

治疗2个月ACTH降至38 pg/ml、血钾4.2 mmol/L;4年随访血压128/84 mmHg(单用乐卡地平20 mg/日),左室射血分数正常化,睾丸病灶体积略减。

General phenotype

中年男性,高血压;双肾上腺大结节样增生及双侧睾丸肾上腺残余瘤。

Imaging

CT示双肾上腺增大伴脂肪密度大病灶(右66×53×88 mm、左55×40×52 mm);阴囊超声及MRI示双侧睾丸内病灶,符合睾丸肾上腺残余瘤。

Laboratory findings

K 3.4 mmol/L;ACTH 921 pg/ml;皮质醇117 nmol/L;肾素9 μUI/ml;醛固酮22.8 ng/L;睾酮30.4 nmol/L;DHEAS 17.8 μmol/L;雄烯二酮31 ng/ml;17OHP 8 ng/ml;11-脱氧皮质醇30 ng/ml。

Management

地塞米松0.5 mg每日一次。

Pathology

未行睾丸活检(患者拒绝)。

Genetic variants

c.2T>C, p.Met1Thr

Evidence level

See source

Clinical history

See source

Growth and development

See source

External genital examination

See source

Limitations

See source

Cite this resource

DSD Research Library | 5-alpha reductase deficiency · 46,XY · DSD-T270 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T270?version=v1.4.0